Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Vietnam OEM insole and pillow supplier

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Customized sports insole ODM Indonesia

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Indonesia graphene product OEM service

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.China insole OEM manufacturer

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Vietnam ergonomic pillow OEM supplier

Scientists studying the DNA of Filipinos have found that, rather than farming, climate change may have played a more significant role in driving the mass movement of populations in various directions. Over 50 millennia, at least five major immigration waves have successively populated the Philippines, the most comprehensive survey of genetic variations in the country to date shows. This Uppsala University study, published in the scientific journal PNAS, comprises 2.3 million DNA markers from some 1,000 individuals. “Our findings suggest that instead of farming, climate change may have played a more important role in driving the mass movement of populations in various directions,” says Maximilian Larena, researcher at Uppsala University’s Department of Organismal Biology and first author of the study. The Philippines’ more than 7,000 islands have always been a link between Southeast Asia, Australia, New Zealand, and the Polynesian islands of the Pacific Ocean. For millennia, the archipelago has served as a corridor for migration from one continent to another. In a new study, a group of researchers from Australia, Taiwan, the Philippines, and elsewhere, led by Uppsala University, reveal the huge scale and complexity of the Filipino population’s origins, kinship patterns, and genetic diversity. By typing 2.3 million DNA markers that are variable in us humans, and then using computational methods, the scientists have investigated the Filipinos’ DNA. In doing so, they analyzed these markers from more than 1,000 individuals, representing 115 Filipino cultural groups. The study shows that over the millennia, at least five major waves of immigration built up the population of the Philippines. Different ethnic groups arrived successively. Negritos, the first Filipinos, were followed by various groups, including those who call themselves the Manobo and Sama. The last three population waves occurred between 15,000 and 7,000 years ago — a period in which climate change caused geographical transformations of the region. Sea levels rose, for example. Sunda, until then a large, fertile land mass between Southeast Asia and Oceania, was inundated and the land bridge between Taiwan and southern China was submerged beneath the waters. “Our study debunks a view that has dominated research on human history: that language, ways of life, culture, and people move together as a single unit — a ‘Neolithic package’, as it’s often called. We’re able to show that new groups of people migrated to the Philippines more than seven millennia ago, and it was these groups that took the Austronesian languages with them. It wasn’t until three thousand years later that agriculture was taken there, probably by related groups. So that happened a long time afterwards,” says Professor Mattias Jakobsson, senior author of the study. Reference: “Multiple migrations to the Philippines during the last 50,000 years” by Maximilian Larena, Federico Sanchez-Quinto, Per Sjödin, James McKenna, Carlo Ebeo, Rebecca Reyes, Ophelia Casel, Jin-Yuan Huang, Kim Pullupul Hagada, Dennis Guilay, Jennelyn Reyes, Fatima Pir Allian, Virgilio Mori, Lahaina Sue Azarcon, Alma Manera, Celito Terando, Lucio Jamero Jr, Gauden Sireg, Renefe Manginsay-Tremedal, Maria Shiela Labos, Richard Dian Vilar, Acram Latiph, Rodelio Linsahay Saway, Erwin Marte, Pablito Magbanua, Amor Morales, Ismael Java, Rudy Reveche, Becky Barrios, Erlinda Burton, Jesus Christopher Salon, Ma. Junaliah Tuazon Kels, Adrian Albano, Rose Beatrix Cruz-Angeles, Edison Molanida, Lena Granehäll, Mário Vicente, Hanna Edlund, Jun-Hun Loo, Jean Trejaut, Simon Y. W. Ho, Lawrence Reid, Helena Malmström, Carina Schlebusch, Kurt Lambeck, Phillip Endicott and Mattias Jakobsson, 22 March 2021, Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.2026132118

Magnetogenetics offers a new approach to brain science, enabling the manipulation of neurons via magnetic fields, potentially revolutionizing treatments for neurological and psychiatric conditions. Credit: SciTechDaily.com Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using magnetic fields. This new method, which has been successfully tested in mice, offers promise for treating neurological and psychiatric disorders by allowing precise activation or inhibition of neurons without the need for invasive procedures. Magnetogenetics and Brain Control A new non-invasive technology enables the control of specific brain circuits using magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, The Rockefeller University, and the Icahn School of Medicine at Mount Sinai. This technology shows great potential as a tool for brain research and as a foundation for future treatments of diverse neurological and psychiatric conditions, including Parkinson’s disease, depression, obesity, and complex pain. The new gene therapy technology is described in a paper published on October 9 in the journal Science Advances. The researchers performed experiments in mice showing that it can switch on or off selected populations of neurons, with clear effects on the animals’ movements. In one experiment, they used it to reduce abnormal movements in a mouse model of Parkinson’s disease. A gene therapy allows precise magnetic field control of specific brain circuits without implanted devices. The image shows restricted mRNA expression of the genetically encoded magnetic sensor (red) in dopaminergic neurons type 2 (green) in the mouse striatum that regulate the initiation of movement. Dopaminergic neurons type 1 (cyan) and cell nuclei shown with dapi staining (blue). Credit: Dr. Santiago Unda “We envision that magnetogenetics technology may someday be used to benefit patients in a wide range of clinical settings,” said study senior author Dr. Michael Kaplitt, professor and executive vice-chairman of neurological surgery at Weill Cornell Medicine and director of Movement Disorders Surgery at NewYork-Presbyterian/Weill Cornell Medical Center. The study was a collaboration between Dr. Kaplitt’s laboratory and the laboratories of Dr. Jeffrey Friedman, the Marilyn M. Simpson Professor in the Laboratory of Molecular Genetics at The Rockefeller University; and Dr. Sarah Stanley, an assistant professor in the Department of Medicine at the Icahn School of Medicine at Mt. Sinai. The study’s first author was Dr. Santiago Unda, a postdoctoral researcher in Dr. Kaplitt’s laboratory. Non-Invasive Techniques for Neural Modulation Controlling brain circuits in real-time, in a way that allows animals—or humans—to move around normally, has been a major goal for neuroscientists, but a very challenging one. In the laboratory, optogenetics technology, for example, can make selected neurons switch on or off immediately with light pulses, but requires an invasive apparatus for delivering those light pulses to the brain. In the clinic, deep brain stimulation permits modulation of brain regions, but this also requires a permanently implanted device and greater precision also remains a goal. After doing early work on magnetogenetic technology as an alternative to other approaches, Dr. Friedman and Dr. Stanley joined forces with Dr. Kaplitt, a pioneer of brain-targeted gene therapies, to develop a method of this type with the potential for clinical applications. Proof of Concept and Future Prospects The resulting approach uses gene therapy techniques to deliver an engineered ion-channel protein to a desired type of neuron. The ion channel protein essentially works as a switch to turn affected neurons on or off, and is sensitive to a magnetic field because it includes an antibody-like protein that sticks to a natural iron-trapping protein called ferritin. While the gene therapy is delivered to precise brain regions through a minimally invasive surgery, a sufficiently strong magnetic field can then exert enough force on the ferritin-trapped iron atoms to open or close the channel—activating the neuron or inhibiting it, depending on the design, without the need for an implanted device or drug. In one proof of concept, the team injected the gene therapy for the magnetically sensitive channels into specific neurons within a movement-controlling region called the striatum in mice; they then used the magnetic field from a magnetic resonance imaging machine to activate the neurons and markedly slow, even freeze, the mice’s movements. In another experiment, they reduced neuronal activity in a brain region called the subthalamic nucleus to ameliorate movement abnormalities in a Parkinsonism mouse model. The researchers showed that their method can work even when using a much smaller and less expensive “transcranial magnetic stimulation” device, which is often used currently in the clinic to treat patients with depression, migraine, and other conditions. The experiments uncovered no safety issues, and the researchers noted that normal ambient magnetic fields would be far too weak to trigger magnetogenetic switches inadvertently. The team now intends to explore potential clinical applications including treatments for psychiatric disorders and even chronic pain in peripheral nerves. They also will continue to explore and optimize the magnetogenetics technology itself. “Being able now to do directional manipulations of brain activity with this relatively simple system is going to be very important in helping us better understand the underlying principles to help further advance this new technology,” Dr. Unda said. Reference: “Bidirectional regulation of motor circuits using magnetogenetic gene therapy” by Santiago R. Unda, Lisa E. Pomeranz, Roberta Marongiu, Xiaofei Yu, Leah Kelly, Gholamreza Hassanzadeh, Henrik Molina, George Vaisey, Putianqi Wang, Jonathan P. Dyke, Edward K. Fung, Logan Grosenick, Rick Zirkel, Aldana M. Antoniazzi, Sofya Norman, Conor M. Liston, Chris Schaffer, Nozomi Nishimura, Sarah A. Stanley, Jeffrey M. Friedman and Michael G. Kaplitt, 9 October 2024, Science Advances. DOI: 10.1126/sciadv.adp9150 Many Weill Cornell Medicine physicians and scientists maintain relationships and collaborate with external organizations to foster scientific innovation and provide expert guidance. The institution makes these disclosures public to ensure transparency. This work was supported by the National Institute of Neurological Disorders and Stroke and the NIH Office of the Director, both part of the National Institutes of Health, through grant numbers R01NS097184, OT2OD024912, and the JPB Foundation.

Graphical representation of tablets of solid-state biologics dissolving in water (left), activating the biological machinery for on-demand manufacturing (right). Credit: Designed by Ehsan Faridi and Ehsan Keshavarzi (Inmywork Studio) The Breakthrough Has Potential Applications in Health Care and Scientific Research Researchers have developed a new technique to store biological substances like RNA and proteins in a solid form. This solid-state storage resembles the form of a pill or tablet, which can be dissolved in water when needed. This groundbreaking approach addresses prevailing challenges in preserving and managing products extracted from living cells, vital for various medical and scientific research endeavors. Biological materials, essential in creating new drugs and tools for diagnostic tests, such as mRNA, enzymes, and antibodies, are notably vulnerable to variations in environmental conditions during storage, transit, and usage. Improper storage and handling can lead them to deteriorate or lose their functionality, posing significant barriers to their availability in regions with limited resources or those that are underserved. For example, the Pfizer COVID vaccine rollout was limited in speed and breadth due to the need for deep freezers for storage and transport. More broadly, even when refrigeration infrastructure is present, failures occurred in over 10% of cases, resulting in over $35 billion in losses annually according to IQVIA Institute for Human Data Science. A New Method for Preserving Biologics To overcome some of the key limitations, researchers at California Polytechnic State University (Cal Poly) in San Luis Obispo, CA, have developed a new method for storing biological materials with vast potential for use by the scientific and medical communities. When most of us open our medicine cabinets, we find pharmaceutical drugs stored in forms such as liquids, powders packaged in capsules, pills, and tablets. Pharmaceuticals have proven that each form plays an important role in how the medication is stored and used. Apart from a few exceptions, biological materials such as medications, are currently limited to being stored as frozen or refrigerated liquids and freeze-dried powders. The absence of a tablet-like form has limited the field, often making it challenging to reach the locations and users where they are needed. “Just as tablets have changed the way we take medications, the solid-state storage platform opens new possibilities for how we handle and use biological materials, unlocking the potential for existing therapies and emerging biotechnologies,” said Dr. Javin Oza, associate professor in chemistry and biochemistry, who led the research on the new storage platform. From Freezing to Room-Temperature Storage Most biological materials require storage as liquids which are frozen in deep freezers for the duration of their shelf life. As a society, we accomplish this through a complex and integrated system of refrigerators and freezers, known as the cold-chain. In recent years, many research teams, including the group at Cal Poly have made progress in freeze-drying biological materials, which has improved the way they are stored and handled, but the use of freeze-drying remains limited. The solid-state storage of biologics represents the next big step because tablets provide unique advantages to better preserve the material they encapsulate. For example, the innovation allows researchers to be able to package biological materials into tablets that can be stored on a shelf at room temperature, and added to water to be dissolved for on-demand use. In addition to ensuring the stability and activity of the biological materials, solid-state storage has been developed to ensure that tablets quickly disintegrate and dissolve into water. Simplifying Biologic Storage and Use “Our innovation makes storing and using biologics as easy as an Alka-Seltzer tablet, just drop it into water, mix, and it’s ready to go,” Oza added. As a test case for the solid-state storage platform’s ability to support a complex mixture of biologics, the team demonstrated that the cell’s machinery capable of decoding genetic information into making RNA and proteins can be stored in a solid-state. When added to water, the machinery reactivates to decode genetic information as if it were still within the cell. The team also went a step further to demonstrate that emerging biotechnology tools such as CRISPR can be activated after storage in a solid-state. The team’s results demonstrate potential for a wide range of applications. The ability to store biologics at room temperature and activate them on demand could be useful for delivering therapeutics to remote locations where the cold-chain is unavailable. For instance, one could envision portable, on-demand production of vaccines in remote locations. The platform could also be used for diagnostic testing of anything from COVID-19 screening to testing wastewater contaminants, simply by changing the composition of the tablets. For utilization in the field, the solid-state storage has the added benefit of being simple to use, reducing the need for specialty training of technicians, further improving access at the point of need. Further improvements to the platform will be needed to suit specific use cases. The researchers anticipate that additional modifications such as coatings could help the solid-state storage be more suitable for withstanding extreme environments such as heat, humidity, and chemicals. Additionally, continued improvements in treatments and coatings to the solid-state biologics could lead to biological medication tablets that can be taken orally rather than through injections. If successful, medications such as insulin and Humira (immunosuppressive treatment for arthritis) could someday be taken orally rather than through injections, improving the quality of life for millions of people. Since the field of biotechnology is growing rapidly, the potential impacts extend beyond health care, and into biomanufacturing, education, and research. The innovation is also likely to impact the way biologics are transported around the globe and into space for the on-demand production of life-saving therapies. Reference: “Development of Solid-State Storage for Cell-Free Expression Systems” by August W. Brookwell, Jorge L. Gonzalez, Andres W. Martinez and Javin P. Oza, 25 July 2023, ACS Synthetic Biology. DOI: 10.1021/acssynbio.3c00111

DVDV1551RTWW78V